More about osteonecrosis
- PMID: 21454842
- DOI: 10.14219/jada.archive.2011.0183
More about osteonecrosis
Comment on
-
The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program.J Am Dent Assoc. 2010 Nov;141(11):1365-70. doi: 10.14219/jada.archive.2010.0082. J Am Dent Assoc. 2010. PMID: 21037195 Clinical Trial.
Similar articles
-
Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.J Clin Oncol. 2011 Jun 10;29(17):e521-2; author reply e523-4. doi: 10.1200/JCO.2011.35.1551. Epub 2011 May 2. J Clin Oncol. 2011. PMID: 21537047 No abstract available.
-
Osteonecrosis of the jaw.Endokrynol Pol. 2011 Jan-Feb;62(1):88-92. Endokrynol Pol. 2011. PMID: 21365586 Review.
-
Denosumab-related osteonecrosis of the jaws.Osteoporos Int. 2011 Jan;22(1):369-70. doi: 10.1007/s00198-010-1177-6. Epub 2010 Mar 20. Osteoporos Int. 2011. PMID: 20306021 No abstract available.
-
Osteonecrosis of the jaw and the role of macrophages.J Natl Cancer Inst. 2011 Feb 2;103(3):232-40. doi: 10.1093/jnci/djq516. Epub 2010 Dec 28. J Natl Cancer Inst. 2011. PMID: 21189409 Review.
-
Osteonecrosis of the jaw.J Am Dent Assoc. 2008 Apr;139(4):398; author reply 398-400. doi: 10.14219/jada.archive.2008.0169. J Am Dent Assoc. 2008. PMID: 18385020 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical